Daniel L. Goodwin’s Pfizer PFE Stock Holding History

Daniel L. Goodwin’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,900	Closed	-$204K	–	96
2022 Q2	$204K	Buy	+3,900	New	+$199K	0.11%	85
2022 Q1	–	Sell	-3,733	Closed	-$220K	–	111
2021 Q4	$220K	Buy	+3,733	New	+$185K	0.1%	93
2019 Q3	–	Sell	-4,989	Closed	-$204K	–	99
2019 Q2	$204K	Hold	4,989	–	–	0.09%	85
2019 Q1	$200K	Hold	4,989	–	–	0.09%	89
2018 Q4	$207K	Hold	4,989	–	–	0.11%	80
2018 Q3	$208K	Hold	4,989	–	–	0.1%	86
2018 Q2	$171K	Buy	+4,989	New	+$170K	0.08%	91

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Daniel L. Goodwin's PFE Position: Q3 2022 in Review

Daniel L. Goodwin sold out of Pfizer (PFE) in Q3 2022, closing a stake of 3,900 shares — an estimated $204K sold.

Daniel L. Goodwin first reported a position in PFE in Q2 2018 and held it in 7 quarters. The position peaked at $220K in Q4 2021. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

Daniel L. Goodwin reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
Daniel L. Goodwin sold 3,900 Pfizer shares in Q3 2022, an estimated $204K.
Daniel L. Goodwin first reported a position in Pfizer in Q2 2018 and held it in 7 quarters.
Daniel L. Goodwin's Pfizer position peaked at $220K in Q4 2021.
3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Daniel L. Goodwin's 13F filing for Q3 2022, filed 19 Oct 2022.